← back to search

Ting Luo

Xuzhou Medical College · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Breast Cancer Treatment Studies, Gut microbiota and health, Oral microbiology and periodontitis research, and Advanced Breast Cancer Therapies.
h-index
35
citations
8,002
works
261
NIH funding
primary concept
Medicine
email

Recent publications

Buchwald-Hartwig aminated pyrene-heterocycles with host-guest-enhanced NIR phosphorescence: DFT-guided design toward breast cancer imaging probes.
2026cited by 0position: contributordoi
Production of low-nitrogen and oxygen biocrude and coupling recovery of nitrogen and phosphorus from hydrothermal liquefaction of sewage sludge with MgCl2
Chemical Engineering Journal 2025cited by 8position: middledoi
Production of high-grade biocrude and recovery of nutrient elements from wet torrefaction of sewage sludge coupled with co-liquefaction with soybean straw
Renewable Energy 2025cited by 6position: middledoi
Exploratory phase II trial of an anti-PD-1 antibody camrelizumab combined with a VEGFR-2 inhibitor apatinib and chemotherapy as a neoadjuvant therapy for triple-negative breast cancer (NeoPanDa03): efficacy, safety and biomarker analysis
Signal Transduction and Targeted Therapy 2025cited by 5position: lastdoi
Identification of candidate biomarkers correlated with the pathogenesis of breast cancer patients
Scientific Reports 2025cited by 3position: middledoi
Preparation of hierarchical HZSM-5 loaded Ni for high-grade bio-oil and low coke formation from catalytic co-pyrolysis of microalgae and LDPE
Chemical Engineering Journal 2025cited by 2position: middledoi
In-depth insight into the synergistic mechanism of in-situ catalytic co-pyrolysis of low-density polyethylene and polystyrene with MgO
Chemical Engineering Journal 2025cited by 2position: firstdoi
Synthesis of HZSM-5@activated carbon for improving aromatic production from catalytic pyrolysis of biomass
Chemical Engineering Journal 2024cited by 30position: middledoi
BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer
Discover Oncology 2024cited by 14position: middledoi
Integrating microwave pyrolysis and hydrotreating for converting low-density polyethylene into jet fuel
Renewable Energy 2024cited by 11position: firstdoi
Comparative hepatoprotective effects of flavonoids-rich fractions from flowers and leaves of Penthorum chinense Pursh in vitro
Journal of Ethnopharmacology 2024cited by 5position: middledoi
Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect.
2024cited by 4position: contributordoi
Pyrotinib and chrysin synergistically potentiate autophagy in HER2-positive breast cancer
Signal Transduction and Targeted Therapy 2023cited by 37position: lastdoi
Cascaded Catalytic Copyrolysis of Microalgae and LDPE with Ni/Biochar and HZSM-5 for Improving High-Grade Bio-Oil Production
ACS Sustainable Chemistry & Engineering 2023cited by 13position: middledoi
Survival and Trends in Annualized Hazard Function by Age at Diagnosis Among Chinese Breast Cancer Patients Aged ≤40 Years: Case Analysis Study.
2023cited by 3position: contributordoi
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China
JMIR Public Health and Surveillance 2023cited by 1position: middledoi
Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China
Infectious Diseases & Immunity 2023cited by 1position: middledoi
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.
2023cited by 1position: contributordoi
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine 2022cited by 2,483position: middledoi
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Journal of Hematology & Oncology 2022cited by 455position: middledoi
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer.
2022cited by 117position: contributordoi
One-Step Carbothermal Reduction Synthesis of Metal-Loaded Biochar Catalyst for <i>In Situ</i> Catalytic Upgrading of Plastic Pyrolysis Products
ACS Sustainable Chemistry & Engineering 2022cited by 42position: middledoi
The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1-2N1 Breast Cancer.
2022cited by 1position: contributordoi
Polysaccharides of Sporoderm-Broken Spore of Ganoderma lucidum Modulate Adaptive Immune Function via Gut Microbiota Regulation
Evidence-based Complementary and Alternative Medicine 2021cited by 25position: middledoi
Targets and underlying mechanisms related to the sedative and hypnotic activities of saponins from <i>Rhodiola rosea</i> L. (crassulaceae)
Food & Function 2021cited by 20position: middledoi
Accurate Prognostic Prediction for Breast Cancer Based on Histopathological Images by Artificial Intelligence
SSRN Electronic Journal 2021cited by 0position: middledoi
Polysaccharide from spore of Ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: Apoptosis inhibition by reversing microtubule polymerization
Biomedicine & Pharmacotherapy 2020cited by 62position: middledoi
Polysaccharide from <i>Pycnoporus sanguineus</i> ameliorates dextran sulfate sodium‐induced colitis via helper T cells repertoire modulation and autophagy suppression
Phytotherapy Research 2020cited by 24position: middledoi
Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study.
2020cited by 12position: contributordoi
Ethanol extract of Pycnoporus sanguineus relieves the dextran sulfate sodium-induced experimental colitis by suppressing helper T cell-mediated inflammation via apoptosis induction
Biomedicine & Pharmacotherapy 2020cited by 10position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenguang Zhou · Nanchang University8 papers (2022–2025)Liangliang Fan · Nanchang University8 papers (2022–2025)Jiabo Wu · Nanchang University7 papers (2022–2025)Yunpu Wang · Nanchang University7 papers (2022–2025)Jinye Hu · South China Agricultural University7 papers (2022–2025)Weixin Wang · Nanchang University6 papers (2022–2025)Jiyan Su · Guangzhou University of Chinese Medicine5 papers (2018–2021)Yizhen Xie · The First Affiliated Hospital, Sun Yat-sen University5 papers (2018–2021)Mengjiao Wang · Nanchang University5 papers (2023–2025)Muxia Li · Guangzhou University of Chinese Medicine5 papers (2018–2021)Haiwei Jiang · Nanchang University4 papers (2024–2025)Qi Wang · Nanchang University4 papers (2024–2025)Yuhang Hu · Nanchang University4 papers (2024–2025)Ying Lin · Guangzhou University of Chinese Medicine3 papers (2023–2023)Xiaorong Zhong · Nantong University3 papers (2021–2025)Chunwei Jiao · South China Agricultural University3 papers (2018–2020)Zefei Jiang · University of Sydney3 papers (2023–2023)Feng Jin · Hebei University3 papers (2023–2023)Fu‐Sheng Wang · National Clinical Research Center for Digestive Diseases3 papers (2023–2023)Lu Su · Macau University of Science and Technology3 papers (2018–2021)